CUV clinuvel pharmaceuticals limited

Ann: Media release - First stroke patient with afamelanotide, page-9

  1. 1,146 Posts.
    lightbulb Created with Sketch. 1701
    No love from new buyers anyway, that volume shows just how tightly held this stock is. There is tons of research on the benefits of this drug, hell the company even boasts they don't market the drug to anyone but they still have 95% patient retention and a highly profitable, debt free business. Imagine if they started pushing their story to the masses! Like you I'm excited for what is to come, hopefully the Over The Counter creams/lotions will be marketed in a way to garner some real interest in this company. European summer starts 21st June hopefully we hear more about this launch soon.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$10.41
Change
-0.190(1.79%)
Mkt cap ! $519.7M
Open High Low Value Volume
$10.70 $10.70 $10.37 $254.4K 24.18K

Buyers (Bids)

No. Vol. Price($)
6 311 $10.41
 

Sellers (Offers)

Price($) Vol. No.
$10.44 91 3
View Market Depth
Last trade - 11.56am 10/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.